Thiazole Derivatives Inhibit Viral Replication via Host Cell Targeting
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current antiviral drugs target specific viral proteins, leading to high specificity and selectivity but result in drug resistance, and have a long development cycle and high cost when targeting different viruses, with a need for broad-spectrum antiviral solutions that target host molecules vital for viral replication.
Innovation Solution
Development of novel thiazole derivatives that inhibit nucleic acid synthesis in host cells, reducing excessive inflammatory responses and viral replication while being less toxic to normal cells, potentially used alone or in combination with existing antiviral drugs.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If antiviral drugs target specific viral proteins, then high specificity and selectivity are achieved, but drug resistance occurs and development cycle is long and cost is high for different viruses
Solution Approach 1:
Instead of targeting viral proteins (conventional approach), this patent targets host cell proteins (nucleic acid synthesis enzymes and inflammatory response regulators) that are essential for viral replication. This inversion of the target object allows a single drug to be effective against multiple different viruses, achieving broad-spectrum activity while avoiding the need for virus-specific drug development
Solution Approach 2:
The compound is designed to simultaneously inhibit multiple host cell functions: nucleic acid synthesis (affecting viral replication) and excessive inflammatory responses. This multi-functionality allows one drug to address multiple aspects of viral infection across different virus types, enhancing both broad-spectrum activity and reliability
2Reliability
If antiviral drugs inhibit viral replication, then virus concentration is reduced, but excessive inflammation is caused and toxicity to normal cells increases
Solution Approach 1:
The patent modifies the chemical structure parameters of thiazole derivatives (substituents at different positions) to optimize the balance between antiviral efficacy and toxicity. By adjusting molecular parameters, the drug achieves effective inhibition of nucleic acid synthesis and inflammatory responses while reducing harmful effects on normal cells
Solution Approach 2:
The patent converts the harmful excessive inflammatory response into a beneficial target for treatment. By inhibiting the excessive inflammation that occurs during viral infection, the drug reduces tissue damage and improves patient outcomes, turning a harmful side effect of viral infection into a treatable condition
Data Source
AI summary
Provided are applications of a thiazole derivative in treating virus infection and in the preparation of drugs for treating virus infection. Specifically, provided are applications of a compound represented by formula (I) and a pharmaceutical composition comprising the compound represented by formula (I) in treating virus infection and in the preparation of drugs for treating virus infection: